OAC0806 Programmatic outcomes of pre-exposure prophylaxis (PrEP) in a resource constraint high HIV incidence setting in EswatiniOral abstract session with live Q&AC35
OAC0807 PrEP continuum of care and new HIV infections: Long-term follow-up in a large clinical cohortOral abstract session with live Q&AC36
OACLB0101 HPTN 083 interim results: Efficacy of pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB-LA) is maintained across regions and key populationsOral abstract session with live Q&AC43
OACLB0102 HIV infection and unsafe injection practice among children in Sindh, Pakistan: A case-control study of an outbreakOral abstract session with live Q&AC5
OACLB0103 Impact of physical distancing due to COVID-19 on HIV pre-exposure prophylaxis (PrEP) use and sexual behaviour among gay and bisexual men in Australia: Implications for trends in HIV and other sexually transmissible infectionsOral abstract session with live Q&AC56
OACLB0104 Impact of COVID-19 on HIV preexposure prophylaxis care at a Boston community health centerOral abstract session with live Q&AC56
OACLB0105 Cluster randomized trial of an HIV self-testing intervention to promote partner testing and safer sexual behavior among women at high risk of HIV infection in KenyaOral abstract session with live Q&AC34
OAD0102 'Living with HIV does not mean you should lose hope': The importance of assessing resilience within the PLHIV Stigma Index 2.0Oral abstract session with live Q&AD8
OAD0103 Fragile lives. Gay shame, HIV stigma, substance use and structural factors greatly affect Latino gay men living with HIV in San Francisco, California: Implications for mental health interventions globallyOral abstract session with live Q&AD10
OAD0104 Family support as a source of resilience to counter HIV-related stigma among adults on antiretroviral therapy in urban ZimbabweOral abstract session with live Q&AD10
seek-warrow-warrow-eseek-e151 - 160 of 2297 items